Physician profile
Jose Rodriguez
NPI 1346655669
$8,084.14
in general payments reported to CMS, 2019-2025
29 companies · $858 in 2025
The $858 reported for 2025 was more than what 95% of Undersea and Hyperbaric Medicine (Emergency Medicine) providers received nationally (typical 2025 total: $153).
See the full distribution for Undersea and Hyperbaric Medicine (Emergency Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,731 · 2020: $916 · 2021: $1,494 · 2022: $841 · 2023: $841 · 2024: $1,402 · 2025: $858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,101.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,276.98 | 2019-2025 | Grafix Pl, Stravix, Grafix |
| Organogenesis INC. | $1,004.12 | 2020-2025 | Apligraf, Puraply Wound Matrix, Affinity |
| Urgo Medical North America, LLC | $445.43 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Hydrofera LLC | $426.14 | 2021-2023 | Hydrofera Blue, Cutimed Sorbact |
| Kerecis Limited | $342.62 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Melinta Therapeutics, LLC | $273.56 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $237.47 | 2019-2020 | |
| Reddress USA, INC. | $231.15 | 2024-2025 | Actigraft |
| Kci USA, INC. | $212.21 | 2019-2020 | |
| Lifenet Health | $193.42 | 2024 | Theragenesis Wound Matrix |
| Tactile Systems Technology INC | $169.95 | 2020-2024 | Entre Plus, Flexitouch Plus |
| Sechrist Industries INC | $154.77 | 2024 | |
| Osiris Therapeutics INC. | $140.39 | 2019 | |
| Pfizer INC. | $118.13 | 2019 | |
| Reprise Biomedical, INC. | $116.34 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $110.79 | 2021-2025 | Rinvoq |
| Amniox Medical, INC. | $104.18 | 2020 | |
| Misonix INC | $95.29 | 2020 | |
| Cardiovascular Systems INC. | $88.53 | 2021 | |
| Integra Lifesciences Corporation | $77.60 | 2021 | |
| Boston Scientific Corporation | $53.03 | 2024 | Resolution Clip |
| Bard Peripheral Vascular, INC. | $46.61 | 2025 | Fluency Endovascular Stent Graft |
| Allergan, INC. | $41.76 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.84 | 2022-2023 | Gattex |
| Siemens Medical Solutions USA, INC. | $28.12 | 2025 | Mammomat B.Brilliant |
| Next Science LLC | $23.07 | 2023 | Xperience, Surgx, Blastx |
| Bioventus LLC | $14.43 | 2024 | Durolane |
| Solventum Corporation | $14.05 | 2025 | Activ.A.C. |
| Advanced Oxygen Therapy INC. | $9.16 | 2023 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.